Literature DB >> 10400619

Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti.

C Lowenberger1, M Charlet, J Vizioli, S Kamal, A Richman, B M Christensen, P Bulet.   

Abstract

An antimicrobial peptide belonging to the cecropin family was isolated from the hemolymph of bacteria-challenged adult Aedes aegypti. This new peptide, named cecropin A, was purified to homogeneity and fully characterized after cDNA cloning. The 34-residue A. aegypti cecropin A is different from the majority of reported insect cecropins in that it is devoid of a tryptophan residue and C-terminal amidation. The importance of these two structural features on the activity spectrum was investigated using a chemically synthesized peptide. A comparison of the antimicrobial activity spectrum of A. aegypti and Drosophila cecropin A showed a lower activity for the mosquito molecule. A. aegypti cecropin mRNA expression was not detected by Northern blot or reverse transcription-polymerase chain reaction analysis in any immature stage of the mosquito, nor in naïve adults, but it was observed in challenged adults 6 h after bacteria inoculation, and it continued over 7-10 days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400619     DOI: 10.1074/jbc.274.29.20092

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Genetics of mosquito vector competence.

Authors:  B T Beerntsen; A A James; B M Christensen
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Enhancing effect of a protein from Lonomia obliqua hemolymph on recombinant protein production.

Authors:  Ronaldo Z Mendonça; Katia N Greco; Alvaro P B Sousa; Roberto H P Moraes; Renato M Astray; Carlos A Pereira
Journal:  Cytotechnology       Date:  2008-03-02       Impact factor: 2.058

3.  Study of kinetic parameters for the production of recombinant rabies virus glycoprotein.

Authors:  Ronaldo Z Mendonça; Katia N Greco; Roberto H P Moraes; Renato M Astray; M Barral
Journal:  Cytotechnology       Date:  2009-10-20       Impact factor: 2.058

4.  Short-Form Bomanins Mediate Humoral Immunity in Drosophila.

Authors:  Scott A Lindsay; Samuel J H Lin; Steven A Wasserman
Journal:  J Innate Immun       Date:  2018-06-19       Impact factor: 7.349

5.  Formation and loss of large, unstable tandem arrays of the piggyBac transposable element in the yellow fever mosquito, Aedes aegypti.

Authors:  Zach N Adelman; Nijole Jasinskiene; K J M Vally; Corrie Peek; Emily A Travanty; Ken E Olson; Susan E Brown; Janice L Stephens; Dennis L Knudson; Craig J Coates; Anthony A James
Journal:  Transgenic Res       Date:  2004-10       Impact factor: 2.788

Review 6.  Mosquito-fungus interactions and antifungal immunity.

Authors:  P Tawidian; V L Rhodes; K Michel
Journal:  Insect Biochem Mol Biol       Date:  2019-06-29       Impact factor: 4.714

7.  Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae.

Authors:  J Vizioli; P Bulet; J A Hoffmann; F C Kafatos; H M Müller; G Dimopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  Anopheles aquasalis Infected by Plasmodium vivax displays unique gene expression profiles when compared to other malaria vectors and plasmodia.

Authors:  Ana C Bahia; Marina S Kubota; Antonio J Tempone; Waleria D Pinheiro; Wanderli P Tadei; Nágila F C Secundino; Yara M Traub-Csekö; Paulo F P Pimenta
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  The malaria vector mosquito Anopheles gambiae expresses a suite of larval-specific defensin genes.

Authors:  J M Meredith; H Hurd; M J Lehane; P Eggleston
Journal:  Insect Mol Biol       Date:  2008-04       Impact factor: 3.585

10.  Biologically active and C-amidated hinnavinII-38-Asn produced from a Trx fusion construct in Escherichia coli.

Authors:  Chang Soo Kang; Seung-Yeol Son; In Seok Bang
Journal:  J Microbiol       Date:  2008-12-24       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.